EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review

BD Naughton, B Vadher, J Smith, G Smith, SR Chapman, S Dopson, DA Brindley
  • Journal of Generic Medicines The Business Journal for the Generic Medicines Sector, September 2015, SAGE Publishing
  • DOI: 10.1177/1741134316643358


Mr Bernard D Naughton (Author)
Keele University

This publication demonstrates the implications of the European Falsified Medicines Directive on secondary care and provides insight into the obstacles faced by healthcare professionals in protecting patients against the threat of conterfeit medicines in the legal supply chain.

The following have contributed to this page: Mr Bernard D Naughton

In partnership with: